CGTLive®’s Weekly Rewind – April 4, 2025

News
Article

Review top news and interview highlights from the week ending April 4, 2025.

CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind

Welcome to CGTLive®’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. FDA Approves Sanofi’s siRNA Therapy Fitusiran for the Treatment of Hemophilia A and B

The product is marketed under the name Qfitlia.

2. David-Alexandre Gros, MD, on the Work to Bring Porcine Kidney Transplant to the Clinic

The chief executive officer of Eledon Pharmaceuticals also discussed other future plans for the company.

3. European Medicines Agency Requests Pause on Trials for Sarepta’s DMD Gene Therapy Elevidys

The move was made in relation to the previously-announced death of a US teenager who received the therapy.

4. Urgency of Funding and Equity in Neuromuscular Research and Care

Robert Califf, MD, MACC, a cardiologist and former FDA commissioner, discussed the necessity of policy and funding efforts for neuromuscular disorders, the stress on the clinical care system, and the need to acknowledge healthcare inequities.

5. Nanoscope Therapeutics’ Gene Therapy MCO-010 Restores Vision in Patients With Retinitis Pigmentosa

At 12 weeks posttreatment, all 4 of the patients showed improvement in the form of a lower logMAR.







Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine
Surbhi Sidana, MD, an assistant professor of medicine, bone marrow transplantation, and cellular therapy at Stanford
Damien Maura, PhD, a senior scientist at Voyager Therapeutics
© 2025 MJH Life Sciences

All rights reserved.